Endace
✅ Manages appetite loss
✅ Treats breast cancer
✅ Irányítja az endometriumrákot
✅ Aids weight gain
✅ Javítja az életminőséget
Endace contains Megestrol Acetate.
✓ Orvosi ellenőrzés Morgan Ellis — Gyógyszerkutató · 8 év tapasztalat · Utolsó felülvizsgálat: 2026 május
⚡ Quick Answer — What is Endace?
Endace egy tabletta formájú gyógyszer a Cipla gyártásában, mely megestrol acetate itt 40 mg and 160 mg — a synthetic progestin used as appetite stimulant in cancer cachexia and HIV-related anorexia, and as palliative endocrine therapy in advanced hormone-receptor-positive breast cancer and endometrial cancer. Standard appetite-stimulant dose: 400–800 mg/day (typically 800 mg/day in cancer cachexia). Onset of appetite improvement at 1–2 weeks; weight gain (mostly fat, not muscle) at 4–6 weeks. Increased venous thromboembolism risk — caution in immobilised cancer patients; consider DVT prophylaxis. Other warnings: adrenal suppression with prolonged use (mineralocorticoid effect), hyperglycaemia, fluid retention.
📦 Minden rendelést fedez a Újraküldési Garancia — ha a csomagod nem érkezik meg 20 munkanapon belül, újraküldjük.
What Is Endace?
Endace is an oral tablet from Cipla containing megestrol acetate (40 mg and 160 mg). Megestrol is a synthetic progestin with potent appetite-stimulant effects. The dominant modern use is as supportive care for cancer cachexia — the involuntary weight loss that affects most patients with advanced cancer and significantly worsens quality of life and treatment tolerance. It also retains a niche role in palliative endocrine therapy for advanced hormone-receptor-positive breast and endometrial cancer.
Felhasználás és indikációk
- Cancer cachexia — appetite stimulation and weight gain
- HIV-related anorexia and weight loss (less commonly used in 2026 with modern ART)
- Palliative endocrine therapy in advanced HR+ breast cancer — later-line after AI and tamoxifen
- Advanced endometrial cancer palliation
- Off-label alkalmazás: hot flushes in patients who cannot use HRT
Adagolás és szedés módja
- Cancer cachexia / HIV anorexia: 400–800 mg/day (often 800 mg/day) of suspension or tablet equivalent
- Breast cancer palliation: 160 mg/day in divided doses
- Endometrial cancer palliation: 80–320 mg/day in divided doses
- Take with food to improve absorption and reduce nausea.
- Once daily or in divided doses depending on indication.
- Kötelező monitorozás: baseline weight, blood glucose (megestrol commonly raises glucose); BP; signs of DVT; symptoms of adrenal suppression. Periodic FBC.
- For cachexia, expect appetite improvement at 1–2 weeks and weight gain at 4–6 weeks. Most weight gain is fat (not muscle), and adding nutritional support and resistance exercise where possible amplifies benefit.
- Ne szakítsa meg hirtelen after prolonged use — risk of adrenal crisis from progestin-mediated adrenal suppression. Taper under specialist guidance.
Mellékhatások
Gyakori: weight gain (the desired effect in cachexia), increased appetite, fluid retention, hyperglycaemia, breakthrough vaginal bleeding, mood changes, insomnia, sweating, hot flushes (paradoxically, in some patients).
Fontos:
- Venous thromboembolism (DVT, PE) — consider prophylactic anticoagulation in immobilised cancer patients
- Adrenal suppression with prolonged high-dose use
- New-onset diabetes or worsening glycaemic control
- Hypertonia
- Cushingoid features at high doses
- Menstrual irregularities
Figyelmeztetések
- Terhesség: contraindicated. Reliable contraception throughout treatment.
- Szoptatás: Kerülendő.
- Active VTE or recent thrombosis: avoid; alternatives include corticosteroids for cachexia (short-term) or omega-3.
- Diabetes: monitor glucose carefully; insulin or hypoglycaemic dose adjustment likely.
- Adrenal insufficiency: taper, do not stop abruptly after prolonged use.
- Cardiovascular risk factors: caution — fluid retention, hypertension.
Gyógyszerkölcsönhatások
| Kombinálható | Hatás | Teendők |
|---|---|---|
| Insulin or oral hypoglycaemics | Megestrol raises blood glucose — reduced control | Monitor glucose; adjust diabetic medication. |
| Varfarin | Possible INR change | Monitor INR. |
| Other progestins, oestrogens | Stacked progestin / VTE effects | Kerülje a kombinációt. |
| Aromatáz-gátlók | Megestrol provides exogenous progestin — rarely used together; sequence appropriately | Specialist judgment. |
Tárolás
- Szobahőmérsékleten, 15–25°C között, eredeti blistercsomagolásban.
- Out of reach of children and pets.
Kapcsolódó alternatívák a MedsBase-en
További onkológiai gyógyszerek, amelyek e termék mellett elérhetők:
- Endoxan (ciklofoszfamid 50 mg)
- Celkeran (chlorambucil 2 / 5 mg)
- Temotero (temozolomid 20 / 100 mg)
- Temozol (temozolomid 20 mg)
- Lomoother (lomusztin 40 mg)
Összes rákkel szembeni gyógyszer böngészése →
Gyakran Ismételt Kérdések
When will I notice the appetite-stimulant effect?
Improved appetite typically starts at 1–2 hét. Measurable weight gain (mostly fat, with smaller fluid component) at 4–6 hét. Most weight gain is fat — megestrol does not significantly increase lean muscle mass. Adding nutritional support and gentle resistance exercise where possible amplifies the benefit.
Why is venous thromboembolism a risk?
Megestrol is a progestin and shares the VTE risk of all hormonal contraceptives + progestins, particularly in cancer patients (who already carry a 5–10× increased baseline VTE risk). Be alert for unilateral leg swelling, sudden chest pain or breathlessness; seek same-day care if these occur. Consider prophylactic anticoagulation in immobilised cancer patients on megestrol.
Will Endace raise my blood sugar?
Yes — commonly. Megestrol mimics some of the metabolic effects of corticosteroids (impairs insulin action, raises hepatic glucose output). Diabetic patients usually need their hypoglycaemic medication adjusted upward; new-onset diabetes can occur in non-diabetic patients on long-term high-dose megestrol. Monitor capillary glucose weekly initially.
Why must I taper rather than stop Endace?
Long-term high-dose megestrol suppresses the adrenal axis (mineralocorticoid effect on the hypothalamic-pituitary-adrenal axis). Abrupt discontinuation after > 4–6 weeks of high-dose use risks adrenal crisis — nausea, vomiting, hypotension, hypoglycaemia. Taper down over 2–4 weeks under specialist supervision.
Are there alternatives to Endace for cancer cachexia?
Limited options with strong evidence. Kortikoszteroidok (dexamethasone 4 mg/day) provide short-term appetite stimulation but have severe long-term toxicity. Cannabinoids (dronabinol where legal) have modest evidence. Anamorelin (ghrelin agonist) is approved in Japan and some other markets. Olanzapine low-dose has emerging supportive evidence. Nutritional and exercise interventions remain first-line. Discuss with the palliative care team.
Can Endace treat my breast cancer?
Megestrol has a niche role in palliative endocrine therapy for HR+ advanced breast cancer — usually later-line after aromatase inhibitor and tamoxifen failure. It is no longer a first or second-line endocrine choice in most modern practice; CDK4/6 inhibitors + AI / fulvestrant have largely replaced it. Specialist oncology decision.
Is Endace safe in pregnancy?
No — contraindicated. Megestrol is a progestin and may cause fetal masculinisation and other developmental effects. Reliable contraception throughout treatment.
Can I drink alcohol on Endace?
Occasional small amounts are tolerable but heavy drinking compounds the metabolic side effects (hyperglycaemia, hypertension, fluid retention). Discuss with the supportive care team in the context of overall cancer care.
Miért rendelj a MedsBase-ról
Minden tétel egy WHO-GMP tanúsított gyártó. WHO-GMP Újraküldési Garancia: ha egy csomag nem érkezik meg 20 munkanapon belül, ingyenes utánküldést biztosítunk, kérdések nélkül.
Kapcsolódó rákellenes gyógyszerek
További onkológiai gyógyszerek, amelyek e termék mellett elérhetők:
- Cytomid (flutamide 250 mg)
- Bicalumutide (bicalutamide 50 mg)
- Bdenza (enzalutamide 40 mg)
- Tamilong (tamoxifen 10/20 mg)
- Xtane (exemesztán 25 mg)
További lehetőségek az Antirákos Gyógyszerek között
Rangsorolva a MedsBase legutóbbi rendelési adatai alapján — hogy ebben a kategóriában más vásárlók mit választanak.
| Erősség | 40 mg, 160 mg |
|---|---|
| Mennyiség | 30 tabletta, 60 tabletta, 90 tabletta, 180 tabletta |
Endace
Kérdések és válaszok
Endace
Kapcsolódó termékek
Vélemények
Még nincsenek vélemények